Insulin-like growth factor-1 receptor and its ligand regulate the reentry of adult ventricular myocytes into the cell cycle

被引:49
作者
Reiss, K
Cheng, W
Pierzchalski, P
Kodali, S
Li, BS
Wang, SL
Liu, Y
Anversa, P
机构
[1] NEW YORK MED COLL,DEPT MED,VALHALLA,NY 10595
[2] NEW YORK MED COLL,DIV CARDIOL,VALHALLA,NY 10595
关键词
D O I
10.1006/excr.1997.3669
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To determine whether insulin-like growth factor-1 (IGF-1) stimulation in vitro of ventricular myocytes isolated from infarcted hearts is characterized by the reentry of cells into the cell cycle, the expression and kinase activity of cyclins E, A, and E and DNA synthesis were evaluated 5 days after coronary artery occlusion and 24 and 48 h following the addition of IGF-1. Myocytes surviving an acute myocardial infarction were employed because of their increase in surface insulin-like growth factor-1 receptors (IGF-1R). Western blot analysis documented that IGF-1 resulted in an upregulation of cyclins D-1, E, A, and B in viable postinfarcted myocytes. Cyclin E-and A-associated histone H-1, kinase activity and cyclin D-1-associated retinoblastoma protein-associated kinase activity also increased, but cyclin B kinase activity was not enhanced by IGF-1. These changes in cyclins and kinase activities were characterized by a significant increase in the number of cells labeled by bromodeoxyuridine, from approximately 630/10(6) to nearly 9,000/10(6) myocytes, This latter value was reduced by more than 50% by antisense oligodeoxynucleotide to IGF-1R mRNA. However, IGF-1 stimulation did not induce nuclear mitotic division and cytokinesis. In conclusion, the growth-promoting effect of IGF-1 on adult myocytes is regulated by the density of IGF-1R, which conditions the activation of the replicatory machinery of the cells. The failure of IGF-1 to enhance cyclin B kinase activity may be responsible for a block in the cell cycle and the inability of myocytes to progress through the M phase and subsequently divide. (C) 1997 Academic Press.
引用
收藏
页码:198 / 209
页数:12
相关论文
共 38 条
[1]   Insulin-like growth factor-1 and myocyte growth: The danger of a dogma .2. Induced myocardial growth: Pathologic hypertrophy [J].
Anversa, P ;
Kajstura, J ;
Cheng, W ;
Reiss, K ;
Cigola, E ;
Olivetti, G .
CARDIOVASCULAR RESEARCH, 1996, 32 (03) :484-495
[2]  
BASERGA R, 1995, CANCER RES, V55, P249
[3]  
Baserga Renato, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P47
[4]   Aging does not affect the activation of the myocyte insulin-like growth factor-1 autocrine system after infarction and ventricular failure in Fischer 344 rats [J].
Cheng, W ;
Reiss, K ;
Li, P ;
Chun, MJ ;
Kajstura, J ;
Olivetti, G ;
Anversa, P .
CIRCULATION RESEARCH, 1996, 78 (04) :536-546
[5]  
CHENG W, 1995, LAB INVEST, V72, P646
[6]   STRETCH-INDUCED PROGRAMMED MYOCYTE CELL-DEATH [J].
CHENG, W ;
LI, BS ;
KAJSTURA, J ;
LI, P ;
WOLIN, MS ;
SONNENBLICK, EH ;
HINTZE, TH ;
OLIVETTI, G ;
ANVERSA, P .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (05) :2247-2259
[7]   SOME GROWTH-FACTORS STIMULATE CULTURED ADULT-RABBIT VENTRICULAR MYOCYTE HYPERTROPHY IN THE ABSENCE OF MECHANICAL LOADING [J].
DECKER, RS ;
COOK, MG ;
BEHNKEBARCLAY, M ;
DECKER, ML .
CIRCULATION RESEARCH, 1995, 77 (03) :544-555
[8]   INSULIN-LIKE GROWTH-FACTOR-I STIMULATES MYOFIBRIL DEVELOPMENT AND DECREASES SMOOTH-MUSCLE ALPHA-ACTIN OF ADULT CARDIOMYOCYTES [J].
DONATH, MY ;
ZAPF, J ;
EPPENBERGEREBERHARDT, M ;
FROESCH, ER ;
EPPENBERGER, HM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (05) :1686-1690
[9]   INSULIN-LIKE GROWTH-FACTOR-I ENHANCES VENTRICULAR HYPERTROPHY AND FUNCTION DURING THE ONSET OF EXPERIMENTAL CARDIAC-FAILURE [J].
DUERR, RL ;
HUANG, S ;
MIRALIAKBAR, HR ;
CLARK, R ;
CHIEN, KR ;
ROSS, J .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (02) :619-627
[10]   A preliminary study of growth hormone in the treatment of dilated cardiomyopathy [J].
Fazio, S ;
Sabatini, D ;
Capaldo, B ;
Vigorito, C ;
Giordano, A ;
Guida, R ;
Pardo, F ;
Biondi, B ;
Sacca, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (13) :809-814